Is NCT03396250 results overdue?

Yes — results are overdue. Primary completion was 2018-03-26; the FDAAA-801 reporting deadline (2019-03-26) passed 2690 days ago and no results are posted on ClinicalTrials.gov.

A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects

NCT ID	NCT03396250 ↗
Sponsor	Bayer (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-03-26 (ACTUAL)
Reporting deadline	2019-03-26 (completion + 365d)
Days overdue	2690
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `d04ed786bf9d7a20…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03396250. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.